ISSAD are excited to announce that the below speakers will be taking part in the keynote sessions at the ISSAD Conference in November.
Dr Kate O’Brien will be taking part as a keynote speaker on the first day of the conference. In her role, she is responsible for leading WHO’s strategy and implementation to advance the vision of a world where everyone, everywhere, at every age, fully benefits from vaccines for good health and wellbeing. The Department works across all levels of WHO (country, region and headquarters) in collaboration with partners to support countries in achieving the optimum use and impact of vaccines. Dr O’Brien also serves as WHO’s Technical Lead of the COVID Vaccine Pillar (COVAX), a part of the Access to COVID Tools Accelerator (ACT-A). The mission of COVAX is to deliver 2 billion doses of the COVID-19 vaccine by the end of 2021, to help end the acute phase of the pandemic.
Dr Stephanie Schrag is the Epidemiology Team Lead in the Respiratory Diseases Branch, Division of Bacterial Diseases at the Centers for Disease Control and Prevention (CDC). Dr Schrag will be this year’s keynote speaker for the Carol Baker Lecture. Since 2000, she has led the CDC’s program on the prevention of group B streptococcal (GBS) disease and the agency’s domestic and international efforts to prevent the broader problem of neonatal sepsis. Domestically, she leads CDC’s GBS policy activities and served as subject matter lead for CDC’s active surveillance for group B streptococcal invasive infections in 10 states.